ID
Intertrigo
search
Intertrigo
See Also
Interdigital Intertrigo Secondary Infection
Cutaneous Candidiasis
Cellulitis
Tinea Pedis
Tinea Cruris
Angular Cheilitis
Diaper Dermatitis
Erythrasma
Definition
Inflammation and secondary infection at skinfolds
Pathophysiology
Friction between skin at folds
Moisture increased and air flow decreased
Inflammation and maceration results in epidermal erosions and other skin breakdown
Conditions allow for secondary superinfection
Risk Factors
Obesity
Linear worsening in severity with increasing BMI > 30 kg/m2
Diabetes Mellitus
Immunocompromised
state (especially
HIV Infection
)
Incontinence
of urine or stool (with occlusive barriers such as diapers)
Immobility
Hyperhidrosis
Poor hygiene
Hot and humid environments
Organisms
Fungus
Candidal Intertrigo or
Candidiasis
(most common)
Presents with erythema,
Scaling
, satellite lesions and foul odor
Dermatophytes
See
Tinea Pedis
and
Tinea Cruris
Bacteria
Staphylococcus aureus
Beta-hemolytic Streptococcus
Pseudomonas
aeruginosa
Proteus
mirabilis
Proteus
vulgaris
Corynebacterium minutissimum
(
Erythrasma
)
Distribution
Most common sites
Groin
Axillae
Inframammary folds
Interdigital toe web space
Athletes, laborers with closed-toe or tight shoes
Less common sites
Antecubital or popliteal fossa
Umbilicus
Perineum
Neck area in infacts
Angular Cheilitis
Symptoms
Itch
ing, burning, and redness in affected skin fold
Foul odor may be present
Signs
Starts with mild erythema
Later, area may become eroded, macerated, fissured
Labs
Potassium Hydroxide
(KOH) for fungal organisms
Wood's Lamp Examination
Pseudomonas
fluoresces green
Erythrasma
(Corynebacterium) fluoresces coral-red
Differential Diagnosis
Inflammatory conditions
Contact Dermatitis
(Irritant or allergic)
Atopic Dermatitis
Skin Infection
s
Erythrasma
Pyoderma
Scabies
Chronic skin disorders
Seborrheic Dermatitis
Psoriasis
Pemphigus Vegetans
Pemphigus Vulgaris
Lichen Sclerosus
Skin manifestations of endocrine disorders
Acanthosis Nigricans
Hidradenitis Suppurativa
Skin Malignancy
Bowen Disease
(squamous cell cancer in situ)
Paget Disease
Management
Gene
ral
Eliminate skin friction
Consider absorbent (e.g. gauze) or breathable barrier agents between overlapping skin
Eliminate moisture in skin folds with drying agents
Talcum powder
Barrier ointment
Petroleum Jelly (Petrolatum, Vaseline)
Zinc Oxide
Wear light, breathable, or absorbent clothing
Treat infection
Space application 2-3 hours from topical drying or barrier agents
Antifungal
s
Consider initial empiric
Antifungal
therapy
Perform additional testing (e.g.
KOH Preparation
) if fails to improve after initial therapy
First-line:
Topical Antifungal
s
Imidazoles (e.g.
Clotrimazole
,
Oxiconazole
,
Econazole
) cover all fungus (including candida and dermatophytes)
Nystatin
covers only
Cutaneous Candidiasis
(but this is most common)
Second-line: Broad-spectrum
Topical Antifungal
s
Naftifine
(
Naftin
)
Terbinafine
(
Lamisil
)
Ciclopirox
(
Loprox
)
Butenafine
(
Mentax
)
Third-line: Oral
Antifungal
s
Fluconazole
(
Diflucan
) 100-200 mg daily for 7 days (adult dose)
Itraconazole
(
Sporanox
)
Antibiotic
s for
Streptococcus
or
Staphylococcus
See
Erythrasma
See
Tinea Pedis
See
Interdigital Intertrigo Secondary Infection
Topical
Mupirocin
(
Bactroban
)
Oral
Antibiotic
s
See
Cellulitis
Streptococcus
or
MSSA
Dicloxacillin
Cephalexin
MRSA
(consider if abscess present, poorly demarcated or refractory to MSSA
Antibiotic
s)
Add trimethoprim-sulfamethoxazole (e.g.
Septra
) to
Dicloxacillin
or
Cephalexin
OR
Doxycycline
OR
Clindamycin
(depending on
MRSA
sensitivity in community)
Consider
Antibiotic
in combination with topical low dose
Corticosteroid
s (e.g. 1%
Hydrocortisone
)
Prevention
Keep intertriginous areas clean and dry
Change moist or soiled clothing multiple times daily
Weight loss
Avoid heat and humidity
Wear open-toe shoes
Apply skin
Emollient
s and barrier agents frequently
References
Habif (2004) Clinical Dermatology, p. 446-50
Janniger (2005) Am Fam Physician 72(5):833-8 [PubMed]
Kalra (2014) Am Fam Physician 89(7): 569-73 [PubMed]
Type your search phrase here